Farid Badria | Health Professions | Best Researcher Award

Published on by Shen Awards

Prof. Dr. Farid Badria | Health Professions | Best Researcher Award

Mansoura University, Egypt

Dr. Farid A. Badria is a distinguished Professor of Pharmacognosy at the Faculty of Pharmacy, Mansoura University, Egypt, where he also leads the Liver Research Lab (FAB-Lab). With a career spanning over three decades, he has emerged as a leading expert in natural products research, biomedical sciences, and translational medicine. His research portfolio encompasses phytochemistry, biotechnology, drug discovery, liver diseases, and diagnostic biomarker development. A globally recognized scholar, Dr. Badria’s academic contributions have earned him several prestigious awards, including recognition by Stanford University among the top 2% most-cited scientists in his field. He has held visiting positions at top institutions such as the University of Minnesota and University of Mainz, Germany. His work bridges academia and practical applications by emphasizing sustainable drug development from natural sources, making his research relevant both scientifically and industrially. In addition to his prolific publication record and extensive teaching responsibilities, Dr. Badria has played significant roles in academic governance and research ethics in Egypt. He is a member of multiple scientific organizations and has mentored numerous students and researchers. His commitment to scientific excellence, public health, and academic leadership makes him a worthy contender for the Best Researcher Award.

Professional Profile

Education

Dr. Badria’s educational background reflects his deep expertise in pharmacognosy, cell biology, and natural product chemistry. He holds a Ph.D. in Microbial Transformations and Natural Products Chemistry from the University of Mississippi, USA, where he conducted groundbreaking research on microbial metabolism and structural elucidation of bioactive compounds. Prior to this, he earned a Master of Science in Pharmaceutical Cell Biology and Natural Toxins from the University of Minnesota, USA. His early graduate education also includes an M.Sc. in Pharmacognosy and Natural Products Chemistry from Mansoura University, Egypt, where he began his career as a dedicated researcher. Dr. Badria earned his undergraduate degree, a B.Sc. in Pharmaceutical Sciences, from the same institution. His rigorous academic training in both Egypt and the United States provided him with a comprehensive foundation in natural sciences, advanced analytical techniques, pharmacology, and biotechnology. This diverse and multidisciplinary academic formation has empowered him to investigate complex biomedical problems, develop novel therapeutic strategies, and mentor future generations of scientists in both theoretical and applied pharmaceutical sciences. His global educational experience has also facilitated international collaboration and innovation throughout his career.

Professional Experience

Dr. Farid A. Badria has amassed extensive academic and professional experience, serving in various esteemed roles that have shaped pharmaceutical education and research in Egypt and abroad. At Mansoura University, he has held positions ranging from Assistant Professor (1990) to Full Professor (since 2000), and has served as Head of the Pharmacognosy Department, Head of Applied Drug Research, and Director of the Central Research Lab. As the founding head of the Liver Research Lab (FAB-Lab), he has led pioneering work on liver disorders, natural enzyme modulators, and phytotherapy. His international career includes Visiting Professorships in Medicinal Chemistry at the University of Minnesota (USA) and at Universität Mainz (Germany), where he contributed to research on marine-derived drugs, apoptosis, and biomarkers. He has also served as a consultant and research associate in the United States. Additionally, Dr. Badria has actively contributed to academic governance, including roles on the Supreme Pharmacy Council of Egypt, Clinical Pharmacy Program Committee, and Promotion Committee for Pharmacy Professors. His professional journey reflects a harmonious blend of research innovation, academic leadership, and societal impact. His contributions have not only enriched his institutions but also advanced pharmaceutical sciences at the global level.

Research Interest

Dr. Badria’s research interests are interdisciplinary and pioneering, integrating natural product chemistry, biotechnology, pharmacognosy, and modern therapeutic strategies. His major focus lies in identifying novel bioactive compounds from plants, marine organisms, and microbial sources for use in drug discovery and disease treatment. A core area of his research targets liver diseases, particularly fibrosis and hepatocellular carcinoma, using hepatoselective agents and early diagnostic biomarkers. He is also deeply involved in phytotherapy for skin and metabolic disorders, such as alopecia, hyperpigmentation, obesity, and diabetes, through the modulation of key enzymes like aldose reductase and glucosidase. Additionally, Dr. Badria has worked extensively on cancer diagnostics (particularly ovarian and liver cancer), retinal pathology, and viral infections using both biochemical and AI-based models. His work explores enzyme inhibition as a central therapeutic mechanism and includes studies on topoisomerase, tyrosinase, and hyaluronidase inhibitors. His holistic approach also extends to environmental research, where he has developed biomarkers to monitor marine and freshwater pollution. Overall, Dr. Badria’s research combines traditional natural medicine with cutting-edge biomedical technologies, positioning him at the forefront of translational pharmacognosy and integrative therapeutic sciences.

Research Skills

Dr. Badria possesses a comprehensive and advanced skill set in both laboratory and clinical research methodologies. His expertise in natural products chemistry is demonstrated through his extensive use of chromatographic and spectroscopic techniques (HPLC, NMR, MS, IR, UV) to isolate and characterize novel therapeutic compounds. He is highly skilled in microbial transformation, tissue culture, and biological screening assays for evaluating cytotoxicity, antiviral activity, and enzyme inhibition. His work with mammalian cell culture, tumor induction, cryogenic preservation, and plant tissue cloning reflects his deep command over pharmaceutical biotechnology. Dr. Badria also utilizes AI and computational tools in healthcare research for predictive modeling in liver cancer, obesity, and treatment decision-making. His knowledge of biomarker discovery is applied in both clinical diagnostics and environmental science, identifying indicators for diseases and pollutants in human and aquatic systems. He is adept at experimental design, pharmacological evaluation, and interdisciplinary collaboration. These skills enable him to translate theoretical insights into practical applications, particularly in liver disease therapy, cancer detection, and anti-inflammatory drug development. Dr. Badria’s methodological rigor and technical proficiency are key strengths that drive the success and innovation of his research programs.

Awards and Honors

Dr. Badria’s exceptional research achievements have been recognized with numerous prestigious awards and honors, both nationally and internationally. Most notably, he was cited by Stanford University among the top 2% most-cited scientists in Medicinal and Biomolecular Chemistry. He received the World Intellectual Property Organization (WIPO) Gold Medal in 2011 as the “Best Inventor in Egypt,” and the Third World Academy of Sciences (TWAS) Prize in 2013 for public science communication. His national accolades include multiple State Recognition Awards in Medicine from the Egyptian Academy of Science and Merit of First Class from the President of Egypt in 1998. Internationally, he was honored with the Khawarizmi International Award (Iran, 2000), the NAM S&T Fellowship, and fellowships from UNESCO and the Arab Development Fund. Dr. Badria is also a member of several elite scientific bodies including the American Association for the Advancement of Science (AAAS), New York Academy of Sciences, and the American Society of Pharmacognosy (ASP). These accolades highlight not only his research excellence but also his contributions to science policy, innovation, and knowledge dissemination across borders.

Conclusion

In conclusion, Dr. Farid A. Badria exemplifies the qualities of an outstanding researcher whose work transcends disciplinary boundaries and geographic limitations. His career is characterized by an unwavering commitment to scientific advancement, innovation in natural products research, and impactful contributions to public health, particularly in liver disease treatment and diagnostics. Through his leadership in research, education, and institutional development, he has significantly elevated the scientific standing of Mansoura University and Egypt at large. His global engagements, collaborative initiatives, and mentoring have further amplified the reach and relevance of his work. Dr. Badria’s legacy is built not only on his prolific academic output and technical expertise but also on his dedication to integrating traditional medicine with modern science for the betterment of human health. Given his comprehensive and influential body of work, he is undoubtedly a highly suitable candidate for the Best Researcher Award, representing the highest standards of research integrity, innovation, and social responsibility in the scientific community.

Publications Top Notes

  • Synthesis and biological evaluation of certain α, β-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents
    Authors: HI El-Subbagh, SM Abu-Zaid, MA Mahran, FA Badria, AM Al-Obaid
    Journal: Journal of Medicinal Chemistry 43(15), pp. 2915–2921, 2000
    Citations: 536

  • Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles
    Authors: S Bondock, S Adel, HA Etman, FA Badria
    Journal: European Journal of Medicinal Chemistry 48, pp. 192–199, 2012
    Citations: 266

  • Melatonin, serotonin, and tryptamine in some Egyptian food and medicinal plants
    Author: FA Badria
    Journal: Journal of Medicinal Food 5(3), pp. 153–157, 2002
    Citations: 266

  • Antioxidant and immunomodulatory constituents of henna leaves
    Authors: BR Mikhaeil, FA Badria, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 59(7–8), pp. 468–476, 2004
    Citations: 265

  • Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as antioxidant, anti-inflammatory and analgesic activities
    Authors: ABA El-Gazzar, MM Youssef, AMS Youssef, AA Abu-Hashem, FA Badria
    Journal: European Journal of Medicinal Chemistry 44(2), pp. 609–624, 2009
    Citations: 236

  • Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles
    Authors: BF Abdel-Wahab, GEA Awad, FA Badria
    Journal: European Journal of Medicinal Chemistry 46(5), pp. 1505–1511, 2011
    Citations: 212

  • Synthesis of some new pyrimido[2′,1′:2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents
    Authors: AA Abu-Hashem, MA Gouda, FA Badria
    Journal: European Journal of Medicinal Chemistry 45(5), pp. 1976–1981, 2010
    Citations: 212

  • Natural products for dental caries prevention
    Authors: FA Badria, OA Zidan
    Journal: Journal of Medicinal Food 7(3), pp. 381–384, 2004
    Citations: 189

  • Chemistry and immunomodulatory activity of frankincense oil
    Authors: BR Mikhaeil, GT Maatooq, FA Badria, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(3–4), pp. 230–238, 2003
    Citations: 179

  • Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii Birdwood
    Authors: FA Badria, BR Mikhaeil, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(7–8), pp. 505–516, 2003
    Citations: 165

Kazutomo Sawai | Health Professions | Best Researcher Award

Published on by Shen Awards

Dr. Kazutomo Sawai | Health Professions | Best Researcher Award

President from Hanshin Medical Co-op Daisan Clinic, Japan

Dr. Kazutomo Sawai is a distinguished Japanese physician-researcher specializing in nephrology and Kampo (traditional Japanese) medicine. He has made outstanding contributions to the understanding of glomerular regeneration, diabetic nephropathy, and molecular markers of kidney disease. With over two decades of clinical and research experience, Dr. Sawai combines modern medical science with traditional therapeutic approaches to address complex renal pathologies. His professional journey encompasses high-level academic training, fellowships at prominent institutions, and leadership roles within clinical practice and education. Since 2010, he has served as President of Daisan Clinic in Amagasaki, Hyogo, Japan, where he also champions patient education and community healthcare. Dr. Sawai’s international presence is marked by presentations at global nephrology congresses, highlighting his pivotal research on Connexin43 and Cyr61 expression in diabetic nephropathy and glomerulonephritis. His clinical insights are further enriched through his integration of Kampo medicine, reflected in his successful management of chronic cases through traditional prescriptions. A fellow of multiple Japanese medical societies, he has received notable honors for his scientific achievements. Dr. Sawai remains a committed clinician, educator, and researcher, dedicated to translational nephrology, patient-centered care, and the advancement of integrative medicine practices.

Professional Profile

Education

Dr. Kazutomo Sawai pursued his foundational medical education at the esteemed Kyoto University School of Medicine, obtaining his M.D. in 1995. Demonstrating an early interest in renal pathophysiology, he continued his academic journey by earning a Ph.D. in Renal Physiology from Kyoto University Graduate School of Medicine in 2004. His doctoral work focused on glomerular disease mechanisms and the role of angiogenic and podocyte-specific factors in kidney regeneration. Dr. Sawai’s postgraduate training included a comprehensive residency in internal medicine at Kyoto University Hospital and Saiseikai Nakatsu Hospital between 1995 and 1997. He later undertook specialized fellowships in nephrology and dialysis therapy from 1998 to 2001 at both Saiseikai Nakatsu and Kyoto University Hospitals. Expanding his scope beyond conventional medicine, Dr. Sawai completed dual fellowships in Kampo medicine between 2015 and 2018 at Midorinokaze Clinic and Rakuwakai Otowa Hospital. This diverse academic and clinical training underpins his multidisciplinary approach to kidney care, integrating Western biomedical science with traditional Japanese therapeutics. Dr. Sawai’s strong academic background has laid a robust foundation for his research contributions and clinical leadership, positioning him as a key figure in the evolution of nephrology and holistic patient care in Japan.

Professional Experience

Dr. Sawai has cultivated an illustrious professional career marked by significant academic, clinical, and administrative roles. His early medical career began with residencies in internal medicine at Kyoto University Hospital and Saiseikai Nakatsu Hospital from 1995 to 1997. He then specialized in nephrology and dialysis therapy during fellowships at these institutions through 2001. Dr. Sawai’s academic appointments include a role as Project Researcher in Internal Medicine at Kyoto University in 2004 and a notable tenure as Chief Researcher at the National Cardiovascular Center Research Institute in Osaka from 2004 to 2010. In 2010, he assumed the presidency of Daisan Clinic in Amagasaki, where he continues to practice, lead, and mentor. His responsibilities extend to community health, serving as Medical Director and Adviser for local home care services, and contributing as a committee member overseeing free and low-cost medical programs. He has also taught at Saiseikai Nakatsu Nursing School and Hanshin Cooperative Association Community College. With an integrated focus on internal medicine, nephrology, dialysis, and Kampo medicine, Dr. Sawai’s professional journey reflects a commitment to advancing holistic healthcare, clinical education, and community outreach.

Research Interest

Dr. Sawai’s research interests span the molecular, cellular, and clinical dimensions of nephrology. His work is particularly focused on the pathophysiology of glomerular diseases, including diabetic nephropathy, anti-GBM nephritis, and glomerulonephritis. He has extensively investigated the roles of podocyte-specific genes, such as Cyr61 (CCN1) and Connexin43, in renal injury and regeneration. These studies have led to insights into the mechanisms of podocyte dysfunction and the potential use of angiogenic and regenerative factors in predicting or improving renal outcomes. A pioneer in integrating traditional medicine into modern nephrology, Dr. Sawai has also explored the therapeutic applications of Kampo prescriptions in managing chronic symptoms such as dementia, hypertension, and neuropathic pain. His case studies highlight the efficacy of herbal formulations in complex clinical scenarios that often resist conventional treatment. His broader interest encompasses translational nephrology, where laboratory discoveries can inform clinical practice. With a comprehensive understanding of both biomedical science and traditional Japanese healing systems, Dr. Sawai’s research bridges disciplines to deliver patient-centered, evidence-based, and integrative kidney care. His continuous presence at national and international conferences further demonstrates his commitment to advancing nephrology and promoting the fusion of traditional and modern medical systems.

Research Skills

Dr. Sawai brings a sophisticated portfolio of research skills to the field of nephrology and integrative medicine. Trained in both clinical and bench research environments, he has demonstrated strong capabilities in experimental nephrology, molecular biology, and pathophysiological analysis. His core competencies include immunohistochemistry, gene expression profiling, and biomarker discovery, particularly focusing on proteins like Cyr61 and Connexin43 in renal pathology. His collaborative research has leveraged rodent models of glomerulonephritis and diabetic nephropathy to explore regeneration pathways in the kidney. Dr. Sawai’s ability to translate these findings into clinical insights distinguishes his work in translational medicine. Additionally, his skills extend to clinical trial design, retrospective case analysis, and Kampo prescription efficacy assessment, making him a rare blend of experimental and clinical researcher. He is also an experienced academic presenter and has delivered over 30 presentations at regional, national, and international conferences. His capacity for multidisciplinary collaboration, particularly in combining conventional nephrology with traditional Japanese Kampo medicine, reflects advanced integrative research skills. Through his leadership at Daisan Clinic, he continues to apply these skills in real-world settings, facilitating a seamless interface between research innovation and patient care.

Awards and Honors

Throughout his career, Dr. Kazutomo Sawai has received multiple accolades in recognition of his academic and research excellence. Among the earliest distinctions was the Miyake Memorial Award from Kyoto University Graduate School of Medicine in 2003, acknowledging his contributions to internal medicine and clinical science. In 2004, he was the recipient of the Tsujisaka Memorial Scholarship, awarded for scholarly promise and research potential in the field of renal physiology. The Young Researcher’s Award conferred at the 42nd Annual Meeting of the Japanese Society of Molecular Medicine in 2005 further highlighted his innovative work on glomerular regeneration. He also earned a Travel Grant from the American Society of Nephrology, which enabled him to present his research at international platforms and expand cross-border academic exchange. These honors not only affirm his impactful scientific work but also emphasize his contributions to the global discourse on nephrology. Dr. Sawai’s recognition by both Japanese and international institutions reflects the high quality and significance of his research. His continued academic output and interdisciplinary approach ensure that he remains at the forefront of innovation in renal medicine and integrative therapies.

Conclusion

Dr. Kazutomo Sawai stands out as a clinician-researcher of exceptional caliber, whose multifaceted career bridges the realms of nephrology, internal medicine, and Kampo therapeutics. His academic foundation at Kyoto University, combined with specialized fellowships in nephrology and traditional medicine, has shaped a unique professional identity that is both modern and rooted in tradition. As President of Daisan Clinic, he has made significant contributions to clinical nephrology while also enhancing community health services and medical education. Dr. Sawai’s research has had a profound impact on the understanding of podocyte biology, glomerular regeneration, and diabetic nephropathy, with practical applications for improving patient outcomes. His pioneering integration of Kampo medicine into nephrology offers novel approaches to managing chronic, treatment-resistant conditions. Despite a lack of editorial roles, his active participation in national and international scientific forums and multiple honors confirm his standing in the field. Dr. Sawai exemplifies dedication to science, education, and compassionate patient care, making him an ideal candidate for prestigious recognition such as the Best Researcher Award. His work continues to inspire the next generation of healthcare professionals and researchers in Japan and beyond.

Publications Top Notes

1. Traditional remedy-induced Chinese herbs nephropathy showing rapid deterioration of renal function

  • Year: 1997

  • Authors: Tanaka A, Nishida R, Sawai K, Nagae T, Shinkai S, Ishikawa M, Maeda K, Murata M, Seta K, Okuda J, Yoshida T, Sugawara A, Kuwahara T

  • Journal: Nihon Jinzo Gakkai Shi

2. Human parvovirus B19 infection resembling systemic lupus erythematosus

  • Year: 1998

  • Authors: Tanaka A, Sugawara A, Sawai K, Kuwahara T

  • Journal: Intern Med

3. Concealed hypothyroidism in patients with myeloperoxidase antineutrophil cytoplasmic autoantibodies (MPO-ANCA) positive renal disease

  • Year: 1999

  • Authors: Tanaka A, Maeda K, Sawai K, Okuda J, Sugawara A, Kuwahara T

  • Journal: Clinical Nephrology

4. Intraglomerular metastasis from pancreatic cancer

  • Year: 2001

  • Authors: Yokoi H, Nakata M, Sawai K, Yoshida T, Koshikawa M, Joyama S, Tanaka A, Goto M, Ueda S, Senzaki H, Sugawara A, Kuwahara T

  • Journal: American Journal of Kidney Diseases

5. C4d and C4bp deposition along the glomerular capillary walls in a patient with preeclampsia

  • Year: 2001

  • Authors: Joyama S, Yoshida T, Koshikawa M, Sawai K, Yokoi H, Tanaka A, Gotoh M, Ueda S, Sugawara A, Kuwahara T

  • Journal: American Journal of Kidney Diseases

6. Angiogenic protein Cyr61 is expressed by podocytes in anti-Thy-1 glomerulonephritis

  • Year: 2003

  • Authors: Sawai K, Mori K, Mukoyama M, Sugawara A, Suganami T, Koshikawa M, Yahata K, Makino H, Nagae T, Fujinaga Y, Yokoi H, Yoshioka T, Yoshimoto A, Tanaka I, Nakao K

  • Journal: Journal of the American Society of Nephrology

7. Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis

  • Year: 2004

  • Authors: Yokoi H, Mukoyama M, Nagae T, Mori K, Suganami T, Sawai K, Yoshioka T, Koshikawa M, Nishida T, Takigawa M, Sugawara A, Nakao K

  • Journal: Journal of the American Society of Nephrology

8. Prevention and reversal of renal injury by leptin in a new mouse model of diabetic nephropathy

  • Year: 2005

  • Authors: Suganami T, Mukoyama M, Mori K, Yokoi H, Koshikawa M, Sawai K, Hidaka S, Ebihara K, Tanaka T, Sugawara A, Kawachi H, Vinson C, Ogawa Y, Nakao K

  • Journal: FASEB Journal

9. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury

  • Year: 2005

  • Authors: Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D’Agati V, Devarajan P, Barasch J

  • Journal: Journal of Clinical Investigation

10. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome

  • Year: 2005

  • Authors: Koshikawa M, Mukoyama M, Mori K, Suganami T, Sawai K, Yoshioka T, Nagae T, Yokoi H, Kawachi H, Shimizu F, Sugawara A, Nakao K

  • Journal: Journal of the American Society of Nephrology

Recinda Sherman | Health Professions | Best Researcher Award

Published on by Shen Awards

Dr. Recinda Sherman | Health Professions | Best Researcher Award

North American Association of Central Cancer Registries (NAACCR), United States

Dr. Recinda L. Sherman is a distinguished public health professional specializing in cancer surveillance and epidemiology. She currently serves as the Program Manager of Data Use and Research at the North American Association of Central Cancer Registries (NAACCR), where she oversees the development and dissemination of cancer data products, including the CiNA (Cancer in North America) data series . With a PhD and MPH, Dr. Sherman has a robust academic background that underpins her extensive experience in managing large-scale cancer data and contributing to public health research. Her work is pivotal in informing cancer control strategies and health policy decisions across North America.

Professional Profile

Education

Dr. Sherman holds a Doctor of Philosophy (PhD) and a Master of Public Health (MPH), reflecting her deep academic engagement in public health and epidemiology. Her educational journey has equipped her with the expertise necessary for high-level research and data analysis in cancer surveillance. Additionally, she is a Certified Tumor Registrar (CTR), a credential that underscores her proficiency in cancer data collection and registry operations . Her academic and professional qualifications have been instrumental in her contributions to cancer epidemiology and public health initiatives.

Professional Experience

In her role at NAACCR, Dr. Sherman manages data use and research programs, focusing on the quality and utility of cancer registry data. She has been involved in various projects aimed at improving cancer data collection and analysis, including the development of best practices for geocoding in cancer registries . Her professional experience also includes serving as an adjunct professor at Claremont Graduate University, where she contributes to the academic development of future public health professionals . Dr. Sherman’s career reflects a commitment to enhancing cancer surveillance and fostering research that informs public health policy.

Research Interests

Dr. Sherman’s research interests encompass cancer epidemiology, spatial analysis, and health disparities. She has authored numerous publications that explore patterns in cancer incidence and mortality, with a particular focus on geographic and demographic disparities . Her work often involves the application of geospatial techniques to understand the distribution of cancer cases and to identify areas in need of targeted public health interventions. Dr. Sherman’s research contributes to a deeper understanding of the factors influencing cancer outcomes and supports the development of strategies to address inequities in cancer care.

Research Skills

Dr. Sherman possesses a comprehensive skill set in epidemiological research, including expertise in cancer surveillance, spatial epidemiology, and public health data analysis. Her proficiency in geocoding and GIS applications enables her to conduct detailed spatial analyses of cancer data, which are crucial for identifying trends and informing public health strategies . Additionally, her experience in managing large datasets and her knowledge of cancer registry operations position her as a leader in the field of cancer epidemiology. Dr. Sherman’s research skills are integral to her contributions to public health research and policy development.

Awards and Honors

Dr. Sherman’s contributions to cancer epidemiology and public health have been recognized through various awards and honors. While specific accolades are not detailed in the available sources, her leadership role at NAACCR and her involvement in significant research projects underscore her standing in the field. Her work has been instrumental in advancing cancer surveillance practices and in promoting the use of high-quality data for public health decision-making. Dr. Sherman’s professional achievements reflect her dedication to improving cancer outcomes and her impact on public health research.​

Conclusion

Dr. Recinda L. Sherman is a prominent figure in cancer epidemiology, with a career dedicated to enhancing cancer surveillance and informing public health policy. Her academic background, professional experience, and research expertise have positioned her as a leader in the field. Through her work at NAACCR and her academic contributions, Dr. Sherman continues to influence the collection and analysis of cancer data, supporting efforts to reduce cancer disparities and improve health outcomes. Her commitment to public health and her contributions to cancer research exemplify the critical role of epidemiologists in advancing healthcare.

Publications Top Notes

  1. Cancer incidence among Marines and Navy personnel and civilian workers exposed to industrial solvents in drinking water at US Marine Corps Base Camp Lejeune: A cohort study
    Authors: Frank J. Bove, April A. Greek, Ruth Gatiba, Gene T. Shin, Aaron Bernstein
    Journal: Environmental Health Perspectives
    Year: 2024
    Citations: 1

  2. Annual Report to the Nation on the Status of Cancer, Part 2: Early assessment of the COVID-19 pandemic’s impact on cancer diagnosis
    Authors: Serban Negoita, Huann Sheng Chen, Pamela V. Sanchez, Ahmedin M. Jemal, Kathleen A. Cronin
    Journal: Cancer
    Year: 2024
    Citations: 24

  3. Annual Report to the Nation on the Status of Cancer, Part 1: National cancer statistics
    Authors: Kathleen A. Cronin, Susan M. Scott, Albert U. Firth, William G. Cance, Ahmedin M. Jemal
    Journal: Cancer
    Year: 2022
    Citations: 308

  4. Annual Report to the Nation on the Status of Cancer, Part 2: Patient economic burden associated with cancer care
    Authors: Robin Yabroff, Ângela B. Mariotto, Florence K.L. Tangka, Ahmedin M. Jemal, Elizabeth M. Ward
    Journal: Journal of the National Cancer Institute
    Year: 2021
    Citations: 126

  5. Annual Report to the Nation on the Status of Cancer, Part 1: National cancer statistics
    Authors: Farhad Islami, Elizabeth M. Ward, Hyuna Sung, Robin Yabroff, Vicki B. Benard
    Journal: Journal of the National Cancer Institute
    Year: 2021
    Citations: 354

​

Vimala Ramoo | Health Professions | Best Researcher Award

Published on by Shen Awards

Assoc. Prof. Dr. Vimala Ramoo | Health Professions | Best Researcher Award

Associate Professor from Universiti Malaya, Malaysia

Dr. Vimala A/P Ramoo is a distinguished academic and healthcare professional known for her expertise in gerontological nursing, patient safety, and clinical decision-making. With a strong background in nursing practice and education, Dr. Vimala has contributed extensively to healthcare research and nursing curricula in Malaysia and beyond. She holds a prominent position at the University of Malaya and has been instrumental in shaping policy and practice standards within the nursing profession. Dr. Vimala’s scholarly work often focuses on improving the quality of care for older adults, exploring complex clinical situations, and fostering evidence-based nursing interventions. She is widely recognized for her leadership in multidisciplinary research teams and her dedication to mentoring emerging nursing scholars. Her publications in peer-reviewed journals reflect her commitment to enhancing nursing practices through scientific inquiry. Beyond academia, Dr. Vimala is actively involved in outreach and advocacy, striving to elevate the standards of elder care in both institutional and community settings. Her balanced approach to education, practice, and research has garnered her a reputation as a leading voice in Malaysian nursing. With a blend of clinical insight and academic rigor, Dr. Vimala continues to influence health care delivery and nursing education across Southeast Asia.

Professional Profile

Education

Dr. Vimala A/P Ramoo’s academic journey is rooted in a strong foundation in nursing and health sciences. She began her higher education with a Bachelor of Nursing Science degree, equipping her with clinical proficiency and foundational knowledge in patient care. Driven by a passion for continuous learning and academic excellence, she pursued a Master’s degree in Nursing, where she specialized in gerontology and clinical care practices. Her master’s thesis focused on aging populations and patient safety—topics that would later define her research career. Furthering her academic pursuits, Dr. Vimala earned a Ph.D. in Nursing from the University of Malaya, one of Malaysia’s leading research institutions. Her doctoral research emphasized the decision-making processes of nurses in critical care environments, highlighting factors that influence safe and effective patient outcomes. In addition to her formal education, Dr. Vimala has participated in various professional development programs and international workshops related to health education, leadership in nursing, and qualitative research methodologies. These educational experiences not only enhanced her academic qualifications but also shaped her as a researcher, educator, and practitioner. Her educational background laid the groundwork for her impactful contributions to nursing research, particularly in the areas of geriatric care, clinical ethics, and evidence-based nursing practices.

Professional Experience

Dr. Vimala A/P Ramoo brings over two decades of professional experience in nursing, health education, and academic leadership. She currently serves as a senior lecturer at the Faculty of Medicine, University of Malaya, where she teaches undergraduate and postgraduate nursing students. In her academic role, Dr. Vimala designs and delivers coursework in gerontological nursing, patient safety, and clinical decision-making, ensuring students are equipped with the latest knowledge and evidence-based practices. Before transitioning fully into academia, she held various clinical positions in both public and private healthcare settings, where she gained hands-on experience in critical care and elder health services. Her clinical background gives her teaching and research a practical, grounded perspective. In addition to her academic duties, Dr. Vimala plays a key role in departmental committees, research ethics boards, and curriculum development initiatives. She has also served as a research mentor and thesis supervisor to numerous postgraduate students. Her collaborations with interdisciplinary teams extend to national healthcare policy discussions and advisory panels. Through her dual focus on education and practice, Dr. Vimala bridges the gap between nursing theory and application, making her a valuable asset to both the academic and healthcare communities in Malaysia.

Research Interests

Dr. Vimala A/P Ramoo’s research interests lie at the intersection of nursing care, patient safety, and gerontology. Her work focuses on improving healthcare delivery for older adults by exploring clinical decision-making processes, communication in nursing teams, and ethical considerations in caregiving. One of her primary interests is the development of safe and effective nursing practices in long-term care settings, particularly within multicultural and resource-limited contexts. Dr. Vimala also investigates how organizational culture and nurse-patient interactions influence the quality of care and patient outcomes. Her research often adopts qualitative and mixed-method approaches to understand complex human experiences in healthcare environments. Another significant aspect of her work includes examining the role of nurse education in shaping patient safety behavior and clinical competence among nurses. She has contributed to projects on fall prevention, palliative care, and dementia care strategies, aiming to enhance the well-being and dignity of aging populations. Dr. Vimala is deeply interested in advancing evidence-based practices through interdisciplinary collaboration, integrating perspectives from medicine, social work, and public health. Her research not only contributes to scholarly literature but also has direct implications for policy-making, nursing education reforms, and improved standards of geriatric healthcare services.

Research Skills

Dr. Vimala A/P Ramoo possesses a diverse range of research skills that reflect her deep engagement with nursing science and health services research. She is proficient in both qualitative and quantitative research methodologies, with particular expertise in ethnography, phenomenology, and grounded theory. These approaches allow her to explore the lived experiences of patients, caregivers, and healthcare professionals in depth. She is also skilled in statistical analysis and the use of software tools such as SPSS and NVivo, which she employs for data analysis and thematic coding. Dr. Vimala is adept at designing research frameworks, developing validated survey instruments, and conducting literature reviews that support evidence-based practice. Her project management skills are evident in her successful coordination of multidisciplinary research grants and collaborative studies. Furthermore, she has extensive experience in academic writing, publishing in high-impact peer-reviewed journals, and presenting at international conferences. Dr. Vimala is also involved in supervising graduate students and mentoring early-career researchers, enhancing the overall research capacity within her department. Her strong ethical grounding, coupled with an ability to translate research findings into practical interventions, makes her a leader in healthcare research focused on gerontology, clinical decision-making, and nursing education.

Awards and Honors

Dr. Vimala A/P Ramoo has been the recipient of numerous awards and honors in recognition of her outstanding contributions to nursing education and research. Her achievements reflect her commitment to excellence, innovation, and service in the healthcare and academic sectors. Among her most notable accolades is the Excellence in Teaching Award from the University of Malaya, which acknowledges her exceptional performance as an educator and mentor. She has also received Best Research Presentation Awards at several national and international conferences, highlighting the significance and impact of her scholarly work. Dr. Vimala’s research projects have been supported through competitive grants, further affirming her credibility and leadership in nursing research. In addition, she has been invited as a keynote speaker and panelist at global health forums and nursing symposia, underlining her influence and thought leadership in the field. Her work on elder care and patient safety has garnered recognition from professional nursing bodies and government-linked health agencies. These honors not only affirm her individual accomplishments but also underscore her broader impact on improving nursing standards and education in Malaysia and the region. Dr. Vimala continues to be a role model for nurses and scholars aspiring to make meaningful contributions to healthcare.

Conclusion

Dr. Vimala A/P Ramoo stands as a pioneering figure in Malaysian nursing, blending academic excellence, clinical experience, and research innovation to transform healthcare education and practice. Her unwavering commitment to gerontological nursing and patient safety has significantly influenced the quality of care provided to aging populations. Through her roles as an educator, researcher, and clinician, she continues to bridge the gap between theory and practice, ensuring that nursing students are well-prepared to meet the evolving challenges of modern healthcare. Her scholarly contributions, particularly in clinical decision-making and ethical caregiving, offer valuable insights that inform policy and improve patient outcomes. Beyond her academic pursuits, Dr. Vimala is an advocate for equity and compassion in healthcare, promoting culturally sensitive and patient-centered practices. Her mentorship has inspired a new generation of nursing professionals, and her leadership continues to elevate the nursing profession in Southeast Asia. With a career marked by integrity, innovation, and impact, Dr. Vimala remains a respected and influential voice in both national and international healthcare circles. Her ongoing work is not only shaping the future of nursing in Malaysia but also contributing to global conversations on quality healthcare, elder care, and nursing education.

Publications Top Notes

  1. Title: The relationship between job satisfaction and intention to leave current employment among registered nurses in a teaching hospital
    Authors: V. Ramoo, K.L. Abdullah, C.Y. Piaw
    Year: 2013
    Citations: 237

  2. Title: Escalating progression of mental health disorders during the COVID-19 pandemic: Evidence from a nationwide survey
    Authors: L.P. Wong, H. Alias, A.A. Md Fuzi, I.S. Omar, A. Mohamad Nor, M.P. Tan, …
    Year: 2021
    Citations: 164

  3. Title: Educational intervention on delirium assessment using confusion assessment method‐ICU (CAM‐ICU) in a general intensive care unit
    Authors: V. Ramoo, H. Abu, V. Rai, S.K. Surat Singh, A.A. Baharudin, M. Danaee, …
    Year: 2018
    Citations: 76

  4. Title: Knowledge, attitude and practice in relation to catheter‐associated urinary tract infection (CAUTI) prevention: A cross‐sectional study
    Authors: I. Mong, V. Ramoo, S. Ponnampalavanar, M.C. Chong, W.N.F. Wan Nawawi
    Year: 2022
    Citations: 48

  5. Title: Missed nursing care in the Malaysian context: A cross‐sectional study from nurses’ perspective
    Authors: S.T. Nahasaram, V. Ramoo, W.L. Lee
    Year: 2021
    Citations: 35

  6. Title: Nursing practice environment, resilience, and intention to leave among critical care nurses
    Authors: L.Y. Ying, V. Ramoo, L.W. Ling, S.T. Nahasaram, C.P. Lei, L.K. Leong, …
    Year: 2021
    Citations: 34

  7. Title: The impact of organisational communication satisfaction on health care professionals’ work engagement
    Authors: H.J. Abu Dalal, V. Ramoo, M.C. Chong, M. Danaee, Y.I. Aljeesh
    Year: 2022
    Citations: 31

  8. Title: The relationship between psychological distress and religious practices and coping in Malaysian parents of children with thalassemia
    Authors: L.T. Chong, M.C. Chong, L.Y. Tang, V. Ramoo, P.L. Chui, N.T.T. Hmwe
    Year: 2019
    Citations: 30

  9. Title: Intervention to improve intensive care nurses’ knowledge of sedation assessment and management
    Authors: V. Ramoo, K.L. Abdullah, P.S.K. Tan, L.P. Wong, P.Y. Chua
    Year: 2016
    Citations: 30

  10. Title: Challenges for healthcare workers caring for COVID-19 patients in Indonesia: a qualitative study
    Authors: H.W. Setiawan, I.N. Pratiwi, L. Nimah, Z. Pawanis, A. Bakhtiar, …
    Year: 2021
    Citations: 29

  11. Title: Career maturity, psychological resilience, and professional self-concept of nursing students in China: A nationwide cross-sectional study
    Authors: F.F. Lyu, V. Ramoo, Y.X. Wang
    Year: 2022
    Citations: 27

  12. Title: Sedation scoring and managing abilities of intensive care nurses post educational intervention
    Authors: V. Ramoo, K.L. Abdullah, P.S.K. Tan, L.P. Wong, Y.P. Chua, L.Y. Tang
    Year: 2017
    Citations: 21

Karolini Branco | Health Professions | Best Researcher Award

Published on by Shen Awards

Mrs. Karolini Branco | Health Professions | Best Researcher Award

PhD student from Cardiology Institute of Rio Grande do Sul, Brazil

Karolini Branco is a dedicated physiotherapist with a deep specialization in cardiology and a strong passion for research-driven clinical advancement. With a solid academic foundation and progressive experience in both hospital and academic settings, she exemplifies a modern healthcare professional integrating evidence-based practice with compassionate patient care. Her clinical focus lies in postoperative rehabilitation for cardiac patients, with a unique emphasis on respiratory physiotherapy and thoracoabdominal rebalancing methods. Currently pursuing a PhD in Health Sciences: Cardiology, she is actively involved in research that enhances recovery outcomes for patients undergoing coronary artery bypass grafting and other major cardiac procedures. Karolini is also well-versed in developing and implementing ICU-based rehabilitation protocols and early mobilization strategies, contributing significantly to reducing respiratory distress and improving functional recovery in critically ill patients. Beyond clinical excellence, she has contributed to academia by teaching in residency programs and universities, mentoring future professionals in physiotherapy. Her publications highlight innovative and clinically relevant topics, reinforcing her role as a researcher who bridges science and practice. With a strong record of multidisciplinary teamwork, continuous learning, and patient-focused innovation, Karolini is a standout figure in cardiorespiratory physiotherapy and a promising candidate for awards recognizing excellence in clinical research.

Professional Profile

Education

Karolini Branco’s educational journey reflects a consistent and focused progression in cardiopulmonary physiotherapy, culminating in advanced research training. She began her academic career with a Bachelor’s degree in Physiotherapy from the Centro Universitário Cenecista de Osório (2014–2018), where she laid the foundational knowledge in physical therapy sciences. Motivated by a keen interest in cardiac care, she then completed a Multiprofessional Residency in Cardiology at the RS Cardiology Institute (2019–2021), gaining immersive clinical experience in high-acuity cardiac units. Her academic rigor and growing research interest led her to pursue a Master’s degree in Health Sciences: Cardiology (2021–2023), also at the RS Cardiology Institute. Here, she initiated significant research projects related to thoracoabdominal rebalancing and respiratory complications in cardiac surgery patients. Currently, Karolini is pursuing her PhD in Health Sciences: Cardiology (2023–present) at the RS Institute of Cardiology, focusing on the development and evaluation of innovative physiotherapy interventions for improving post-surgical outcomes. Her academic trajectory demonstrates not only dedication to specialized learning but also a strong commitment to contributing to scientific advancements. Each step of her education has strategically equipped her to address complex clinical challenges and conduct impactful research in cardiorespiratory health.

Professional Experience

Karolini Branco has amassed significant hands-on experience across multiple healthcare settings, particularly in cardiopulmonary and critical care physiotherapy. Her career began as a Resident Physiotherapist at the RS Cardiology Institute (2019–2021), where she was immersed in specialized cardiology care, working with complex cases in inpatient and ICU environments. This role honed her clinical skills in early mobilization, mechanical ventilation management, and patient assessment in both pediatric and adult populations. Following this, she advanced to the role of Physiotherapist Assistant I at Moinhos de Vento Hospital (March 2021–July 2024), where she took on greater responsibility in developing and executing personalized rehabilitation programs for post-cardiac surgery patients. Her practice includes conducting functional and respiratory assessments, implementing early mobilization protocols, and contributing to cardiovascular emergency response teams. Her ability to integrate research into clinical routines distinguishes her from peers. Additionally, Karolini has participated in academic teaching and mentorship within university and residency settings, sharing her knowledge and promoting evidence-based care among new practitioners. Her professional journey reflects a well-rounded clinician who thrives in high-pressure environments, is committed to multidisciplinary teamwork, and continuously evolves through research and teaching. This rich blend of experience reinforces her status as a leader in therapeutic cardiac rehabilitation.

Research Interests

Karolini Branco’s research interests are deeply rooted in improving patient outcomes following cardiac events and surgical interventions, with a specific emphasis on respiratory physiotherapy. She is particularly focused on developing, testing, and validating physiotherapeutic interventions that reduce postoperative pulmonary complications and enhance cardiopulmonary function. One of her key research areas includes the Thoracoabdominal Rebalancing Method (RTA), which she investigates as a superior approach to conventional physiotherapy for patients undergoing coronary artery bypass grafting surgery. Additionally, she explores the role of pulmonary impedance as an innovative marker for assessing therapeutic efficacy in obstructive ventilatory disorders. Karolini has also contributed to pediatric research through a systematic review of equations used to predict maximum heart rate in non-athletic children. Her interests span across intensive care rehabilitation, hemodynamic monitoring, non-invasive respiratory techniques, and the integration of personalized rehabilitation protocols into standard post-surgical care. By targeting physiotherapy’s intersection with clinical cardiology, Karolini aims to establish protocols that are both evidence-based and patient-specific. Her PhD research continues to build upon these themes, with the overarching goal of transforming post-cardiac surgery care to minimize complications, accelerate recovery, and improve patients’ quality of life through physiotherapeutic innovation.

Research Skills

Karolini Branco brings a robust suite of research skills that reflect her dual expertise as a clinician and a scientific investigator. She is proficient in designing and conducting randomized clinical trials, a skill evidenced by her work comparing the Thoracoabdominal Rebalancing Method with conventional physiotherapy in cardiac surgery patients. Her ability to manage all stages of research—from proposal writing, ethical approvals, and recruitment to data collection, analysis, and publication—demonstrates high-level competence in applied health research. She is skilled in systematic literature reviews, quantitative data analysis, and evidence synthesis, which supports her work in pediatric cardiopulmonary assessment and adult rehabilitation techniques. Karolini is also adept at utilizing clinical metrics such as hemodynamic variables, pulmonary impedance, and respiratory function indices for research outcomes. Her close collaboration with medical teams allows her to effectively translate research findings into clinical practice, enhancing real-world impact. Moreover, her teaching roles in academic and residency settings underscore her communication and knowledge dissemination skills, both critical for research leadership. Her ongoing doctoral training further hones her expertise in advanced methodologies and fosters a deeper understanding of translational science in cardiology. Collectively, Karolini’s research skills position her as a dynamic and competent investigator in health sciences.

Awards and Honors

While specific awards and honors are not explicitly listed in the provided profile, Karolini Branco’s professional and academic journey strongly suggests a trajectory deserving of recognition. Her selection into a Multiprofessional Residency in Cardiology at the RS Cardiology Institute—a highly competitive and prestigious program—marks a significant early-career achievement. Her continued acceptance into both a Master’s and PhD program in Cardiology at the same institute further reflects academic merit and the trust of her mentors and institution in her capabilities. Moreover, her work on high-impact randomized clinical trials and systematic reviews demonstrates a level of scholarly contribution that is typically recognized in academic and professional circles. Participation in such research projects and her leadership in clinical implementation signal the likelihood of departmental or institutional accolades. Karolini’s teaching contributions in universities and residencies also suggest recognition as a mentor and educator. Her research’s practical application in improving patient outcomes post-cardiac surgery makes her a strong contender for honors like the Best Researcher Award, especially given her multidisciplinary integration and innovation. As her PhD progresses and her international visibility grows, she is poised to receive further formal recognition for her valuable contributions to health science and cardiopulmonary rehabilitation.

Conclusion

Karolini Branco stands out as a highly capable and impactful physiotherapist whose clinical insight and research innovation significantly contribute to the field of cardiopulmonary rehabilitation. Her academic progression—from bachelor’s to PhD—demonstrates a consistent commitment to advancing healthcare through specialized knowledge and evidence-based practices. Her dual roles in clinical care and academic instruction highlight her versatility and dedication to both patient well-being and professional development within her field. Through her research on thoracoabdominal rebalancing, pulmonary function, and postoperative care, Karolini addresses real-world challenges in critical care and surgery recovery. She brings a strong blend of analytical, procedural, and collaborative skills, which are crucial for multidisciplinary clinical research. Her background indicates a strong capacity for leadership in both academic and hospital environments, and her future contributions are likely to further shape cardiopulmonary physiotherapy standards. With a growing portfolio of impactful studies, teaching roles, and specialized expertise, Karolini is not only deserving of recognition like the Best Researcher Award but also positioned to influence national and international best practices in her domain. As she continues her doctoral work and expands her scholarly influence, she remains a promising figure in advancing health outcomes for cardiac patients through physiotherapy-driven solutions.

Publications Top Notes

  1. Title: Thoracic‐Abdominal Rebalancing Method is Superior in Terms of Decreasing Respiratory Distress, Postoperative Pulmonary Complications and Hemodynamic Variables When Compared to Conventional Physiotherapy in Postoperative Patients of Coronary Artery Bypass Grafting Surgery: Randomized Clinical Trial
    Authors: Karolini Reis Branco, Fernanda dos Santos Silveira, Letícia Ferronato, Simone Cristina Jabuonski, Vinícius Serra Peringer, Mariangela Pinheiro de Lima, João Paulo Heinzmann‐Filho, Bruna Eibel
    Year: 2025

  2. Title: Impedância pulmonar como novo marcador de fisioterapia respiratória em adultos com distúrbios ventilatórios obstrutivos
    Authors: Dyovana Silva Dos Santos, Andressa Schenkel Spitznagel, Karolini Reis Branco, Márcio Vinícius Fagundes Donadio, Camila Isabel Santos Schivinski, Daniele Schiwe, João Paulo Heinzmann Filho
    Year: 2019

  3. Title: Equações utilizadas para a predição de frequência cardíaca máxima na população pediátrica não atlética: uma revisão sistemática
    Year: 2019

Maria Lithoxopoulou | Health Professions | Best Researcher Award

Published on by Shen Awards

Assist. Prof. Dr. Maria Lithoxopoulou | Health Professions | Best Researcher Award

Neonatologist -Pediatrics at Faculty of Medicine Aristotle University of Thessaloniki, Greece

Dr. Maria Lithoxopoulou is an esteemed Assistant Professor of Paediatrics-Neonatology at Aristotle University of Thessaloniki, Greece. With over 17 years of clinical experience as a Consultant Neonatologist, she has made significant contributions to neonatal care, focusing on neonatal infections, retinopathy of prematurity, and neonatal nutrition. She holds a Ph.D. in Neonatal Infections and an MBA in Health Administration, showcasing a blend of clinical, research, and administrative expertise. Her research is widely recognized, with 27 published articles, 79 citations, and a Scopus h-index of 5. She has collaborated with various national and international researchers to improve neonatal healthcare outcomes. Her contributions extend beyond neonatology to include ophthalmology, pediatric nutrition, and maternal health, demonstrating a broad and interdisciplinary research approach. Dr. Lithoxopoulou is fluent in Greek and English, with strong technical skills in Microsoft Office and data analysis. Her dedication to academia and research makes her a key figure in advancing neonatal healthcare practices. She is committed to improving neonatal treatment protocols, optimizing drug delivery for preterm infants, and reducing neonatal complications through evidence-based research. With a passion for both clinical and academic excellence, she continues to impact neonatology and pediatrics significantly.

Professional Profile

Education

Dr. Maria Lithoxopoulou has a strong academic background in medicine and healthcare management. She earned her Degree in Medicine from Aristotle University of Thessaloniki, Faculty of Medicine, Greece, in 1994, which laid the foundation for her career in pediatrics and neonatology. She later obtained a License to Practice in Paediatrics in 2003, allowing her to specialize in neonatal care. To further advance her expertise, she pursued a Ph.D. in Neonatal Infections, focusing on Signal Transducer and Activator of Transcription in Neonatal Infection, which she completed in 2012 at Aristotle University of Thessaloniki. In addition to her medical training, she obtained an MBA in Health Administration (2017), which equipped her with the necessary skills to manage and lead healthcare units effectively. She later acquired a Medical Specialty in Neonatology after passing rigorous exams. Her multifaceted education combines clinical, research, and administrative expertise, enabling her to contribute significantly to neonatal medicine, hospital management, and academic research. Dr. Lithoxopoulou’s commitment to education and continuous learning has allowed her to excel in both research and patient care, making her a leading figure in the field of pediatric neonatology.

Professional Experience

Dr. Maria Lithoxopoulou has a distinguished career in neonatology, with extensive experience in both clinical practice and academic research. She began her professional journey as a Consultant Neonatologist at General Hospital of G. Papageorgiou, Aristotle University of Thessaloniki, where she served from 2005 to 2022. During her tenure, she played a critical role in treating preterm and critically ill newborns, optimizing neonatal care protocols, and improving neonatal survival rates. In 2022, she transitioned into academia as an Assistant Professor in Paediatrics-Neonatology at Aristotle University of Thessaloniki, where she continues to mentor medical students, supervise research projects, and contribute to cutting-edge neonatal research. Throughout her career, she has collaborated with multidisciplinary teams in pediatric healthcare, focusing on neonatal infections, retinopathy of prematurity, neonatal nutrition, and early neonatal sepsis management. Her expertise extends to hospital administration, research project management, and neonatal pharmacology, allowing her to bridge the gap between clinical care and medical research. Dr. Lithoxopoulou’s contributions have enhanced neonatal treatment protocols, improved screening techniques for neonatal diseases, and shaped the next generation of neonatologists and pediatricians. Her dedication to both patient care and scientific advancement makes her a leading expert in her field.

Research Interests

Dr. Maria Lithoxopoulou’s primary research interests lie in the field of neonatology, with a strong focus on neonatal infections, neonatal ophthalmology, and neonatal nutrition. She has conducted extensive research on retinopathy of prematurity (ROP), exploring innovative screening techniques, drug delivery methods, and treatment outcomes. Her work also delves into neonatal sepsis, thrombocytopenia, and the effects of maternal health on neonatal outcomes, providing valuable insights into early disease detection and intervention strategies. In addition, she has a growing interest in neonatal pharmacology, particularly in optimizing drug delivery methods for preterm infants to improve treatment efficacy. Dr. Lithoxopoulou is also involved in research concerning pediatric nutrition and the prevention of neonatal malnutrition, emphasizing the role of maternal education in child growth and development. Her interdisciplinary approach has led her to collaborate with researchers in ophthalmology, public health, and biomedical sciences, broadening the impact of her work beyond neonatology. She is committed to advancing evidence-based practices in neonatal care by developing new clinical guidelines, conducting systematic reviews, and engaging in large-scale neonatal health studies. Her research significantly contributes to improving neonatal healthcare standards worldwide.

Research Skills

Dr. Maria Lithoxopoulou possesses advanced research skills in neonatology, clinical trials, and medical data analysis. She has expertise in study design, statistical analysis, and systematic reviews, allowing her to conduct high-quality, evidence-based research. She is proficient in using Scopus, ORCID, and Google Scholar for literature review and citation tracking. Her research skills include quantitative and qualitative data analysis, with experience in handling clinical datasets and patient records to draw meaningful conclusions. She has conducted randomized controlled trials, observational studies, and meta-analyses, particularly in neonatal ophthalmology, neonatal pharmacology, and neonatal infections. Additionally, she is skilled in scientific writing and publishing, with 27 published papers in peer-reviewed journals. She collaborates with multidisciplinary research teams, contributing to studies that impact neonatal healthcare on a global scale. Dr. Lithoxopoulou is also adept at grant writing and securing research funding, helping to advance her work in neonatology. With strong skills in Microsoft Office, PowerPoint presentations, and online research tools, she effectively communicates her findings at national and international conferences. Her expertise in data interpretation and clinical application makes her a valuable asset to neonatal research and academic medicine.

Awards and Honors

Dr. Maria Lithoxopoulou has received recognition for her contributions to neonatology and medical research. She has been acknowledged for her work in neonatal ophthalmology, particularly in improving screening techniques for retinopathy of prematurity (ROP). Her research on neonatal infections and thrombocytopenia has been cited as influential in shaping clinical guidelines for neonatal care. Additionally, she has participated in several national and international research projects, earning grants and funding for her innovative studies. Her dedication to neonatology has also been recognized through invitations to speak at international conferences, where she has presented her findings on neonatal pharmacology, neonatal nutrition, and early disease detection in preterm infants. She has contributed to high-impact medical journals and has played a key role in collaborative neonatal research initiatives. While her h-index (5) and citation count (79) are growing, her research continues to gain recognition in the scientific community. Her commitment to advancing neonatal healthcare through cutting-edge research, academic leadership, and clinical excellence makes her a strong candidate for prestigious research awards in pediatrics and neonatology.

Conclusion

Dr. Maria Lithoxopoulou is a highly accomplished neonatologist and researcher with a strong academic background, extensive clinical experience, and a significant research portfolio. Her work in neonatal infections, ophthalmology, and nutrition has led to valuable advancements in neonatal care and treatment protocols. With 27 research publications, a growing citation impact, and numerous contributions to neonatal medicine, she is a leading expert in her field. While she continues to expand her research influence, her commitment to academia, clinical excellence, and medical innovation makes her an outstanding candidate for the Best Researcher Award.

Publications Top Notes

  • Determination of macronutrient profile and energy composition in human milk via Mid‐Infrared Spectrometer Analysis: An experimental study

    • Authors: Maria Lithoxopoulou, Anastasia Gkampeta, Dimitrios Rallis, Katerina Tzafilkou, Eftychia Drogouti, Christos Tsakalidis
    • Year: 2025

  • A hydrophilic interaction liquid chromatography – Tandem mass spectrometry method for the determination of phenylephrine in dried blood spots from preterm infants

    • Authors: E. Boutou, C. Virgiliou, A.K. Seliniotaki, M. Lithoxopoulou, A. Mataftsi, N. Ziakas, E. Diamanti, N. Raikos, H. Gika
    • Year: 2022

  • Avoiding use of lid speculum and indentation reduced infantile stress during retinopathy of prematurity examinations

    • Authors: A. Mataftsi, M. Lithoxopoulou, A.K. Seliniotaki, P. Talimtzi, E. Oustoglou, E. Diamanti, V. Soubasi, N. Ziakas, A.-B. Haidich
    • Year: 2022

  • Population-Based Studies in Retinopathy of Prematurity and Screening Criteria Used

    • Authors: Stella Moutzouri, Aikaterini K. Seliniotaki, Maria Lithoxopoulou, Anna-Bettina Haidich, Nikolaos Ziakas, Asimina Mataftsi
    • Year: 2022

  • Clinical chorioamnionitis and histologic placental inflammation: association with early-neonatal sepsis

    • Authors: D. Rallis, M. Lithoxopoulou, S. Pervana, P. Karagianni, I. Hatziioannidis, V. Soubasi, C. Tsakalidis
    • Year: 2021

  • Efficacy and safety of mydriatic microdrops for retinopathy of prematurity screening: an external pilot crossover randomized controlled trial

    • Authors: A.K. Seliniotaki, M. Lithoxopoulou, P. Talimtzi, E. Georgiou, E. Diamanti, N. Ziakas, A.-B. Haidich, A. Mataftsi
    • Year: 2021

  • Potential benefit from the implementation of the Kaiser Permanente neonatal early-onset sepsis calculator on clinical management of neonates with presumed sepsis

    • Authors: I. Kopsidas, N.-M. Molocha, E. Kourkouni, S. Coffin, D. Gkentzi, E. Chorianopoulou, G. Dimitriou, A. Kapetanaki, G. Karavana, M. Lithoxopoulou, et al.
    • Year: 2021

  • Reducing duration of antibiotic use for presumed neonatal early-onset sepsis in Greek NICUs: A “low-hanging fruit” approach

    • Authors: I. Kopsidas, G.-C. Tsopela, N.-M. Molocha, E. Bouza, E. Chorafa, E. Chorianopoulou, V. Giapros, D. Gkentzi, T. Gkouvas, A. Kapetanaki, et al.
    • Year: 2021

  • A neonate with intrauterine growth restriction and pseudo-Bartter syndrome due to severe maternal eating disorder: A case report

    • Authors: E. Babatseva, I. Chatziioannidis, A.A. Tagaraki, D. Tramma, K. Dampala, E. Chatzitoliou, E. Papacharalambous, G. Mitsiakos, C. Tsakalidis, P. Karagianni, et al.
    • Year: 2020

  • Alternative mydriasis techniques for retinopathy of prematurity screening

    • Authors: A.K. Seliniotaki, E. Prousali, M. Lithoxopoulou, S. Kokkali, N. Ziakas, V. Soubasi, A. Mataftsi
    • Year: 2020

 

Sefa Eldemir | Health Professions | Young Scientist Award

Published on by Shen Awards

Sefa Eldemir | Health Professions | Young Scientist Award 

Research Assistant , Sivas Cunhuriyet Üniversity ,Turkey .

Sefa Eldemir is a promising researcher in the field of physiotherapy and rehabilitation, with a notable publication record that includes 11 publications in high-impact journals since August 2019. His research primarily focuses on improving motor functions in patients with neurological disorders, particularly those with multiple sclerosis and Parkinson’s disease. His work has garnered significant attention, as indicated by his H-index of 16 and a total of 11 citations, showcasing the relevance and impact of his findings in the scientific community.

 

Profile
Education

Sefa Eldemir has a solid educational background in physiotherapy and rehabilitation, having completed his degree in this field with a focus on neurological disorders. His academic journey has equipped him with a comprehensive understanding of human physiology and the principles of rehabilitation, allowing him to effectively contribute to research and clinical practices. His commitment to furthering his knowledge is evident through his pursuit of advanced studies, which have bolstered his expertise in the latest rehabilitation techniques.

Professional Experience

Currently, Sefa Eldemir is a dedicated researcher and practitioner in the field of physiotherapy. His professional roles involve working directly with patients, applying his knowledge to develop effective rehabilitation programs tailored to individuals with neurological conditions. He is actively engaged in clinical practice, where he integrates research findings into therapeutic interventions, ensuring that his work translates into real-world benefits for his patients.

Research Interests

Eldemir’s primary research interests lie in the rehabilitation of patients with neurological disorders, particularly focusing on multiple sclerosis and Parkinson’s disease. He investigates the effectiveness of various therapeutic approaches, including telerehabilitation and exercise-based interventions, aimed at improving motor functions and overall quality of life for individuals facing these challenges. His research aims to bridge the gap between clinical practice and scientific inquiry, leading to more effective rehabilitation strategies.

Research Skills

With a strong foundation in research methodologies, Sefa Eldemir possesses essential skills in both qualitative and quantitative research techniques. He is proficient in data collection and analysis, which enables him to critically evaluate the outcomes of his studies. His experience includes conducting randomized controlled trials and systematic reviews, highlighting his ability to contribute valuable insights to the field of physiotherapy. Eldemir’s analytical skills, coupled with his ability to collaborate with interdisciplinary teams, further enhance his research capabilities.

Awards and Recognition

Sefa Eldemir’s contributions to the field of physiotherapy have not gone unnoticed. He has received several accolades for his research, including recognition in prestigious journals and conferences. His work has led to significant advancements in understanding the rehabilitation of neurological disorders, earning him an H-index of 16 and multiple citations in influential publications. These achievements underscore his commitment to excellence in research and his potential for future contributions to the field.

Conclusion

Sefa Eldemir’s innovative approach to research and his commitment to addressing significant challenges in rehabilitation make him a suitable candidate for the Young Scientist Award. His work exemplifies the spirit of this award by contributing valuable insights into the treatment of debilitating conditions through advanced rehabilitation techniques. Recognizing his efforts would not only highlight his achievements but also inspire other young researchers in the field to pursue impactful scientific inquiries. His continued contributions promise to advance knowledge and improve therapeutic practices in the realm of physiotherapy and beyond.

Publications Top Notes

 

  • The functional reach test in people with multiple sclerosis: a reliability and validity study
    Year: 2022
    Journal: Physiotherapy Theory and Practice 🏃‍♂️📚
  • Effects of Pilates-based telerehabilitation on physical performance and quality of life in patients with multiple sclerosis
    Year: 2024
    Journal: Disability and Rehabilitation 💪🧘‍♀️
  • Associations between fatigue and physical behavior in patients with multiple sclerosis with no or minimal disability
    Year: 2021
    Journal: Fatigue: Biomedicine, Health & Behavior 🥱📊
  • Hamstring weakness at 90° flexion of involved knee as an indicator of the function deficit in males after anterior cruciate ligament reconstruction (ACLR)
    Year: 2021
    Journal: Acta of Bioengineering and Biomechanics 🦵🔬
  • The effect of task-oriented circuit training-based telerehabilitation on upper extremity motor functions in patients with Parkinson’s disease: A randomized controlled trial
    Year: 2023
    Journal: Parkinsonism & Related Disorders 🧠👐
  • Role of Telerehabilitation in Upper Extremity Rehabilitation of Parkinson’s Patients: Review of the Literature
    Year: 2022
    Journal: Cumhuriyet Medical Journal 📖🧑‍⚕️
  • The effects of standard and modified LSVT BIG therapy protocols on balance and gait in Parkinson’s disease: A randomized controlled trial
    Year: 2024
    Journal: Brain and Behavior 🧠👣
  • Functional performance, leg muscle strength, and core muscle endurance in multiple sclerosis patients with mild disability: a cross-sectional study
    Year: 2022
    Journal: Motor Control 💪🧍‍♂️
  • Effects of modified-constraint induced movement therapy based telerehabilitation on upper extremity motor functions in stroke patients
    Year: 2024
    Journal: Brain and Behavior 🧠🏥
  • The reliability and validity of the Turkish version of the dual-task questionnaire in patients with multiple sclerosis
    Year: 2022
    Journal: Multiple Sclerosis and Related Disorders 🇹🇷📝